Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study
出版年份 2018 全文链接
标题
Body mass index may predict the response to ipilimumab in metastatic melanoma: An observational multi-centre study
作者
关键词
-
出版物
PLoS One
Volume 13, Issue 10, Pages e0204729
出版商
Public Library of Science (PLoS)
发表日期
2018-10-02
DOI
10.1371/journal.pone.0204729
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
- (2018) Jennifer L McQuade et al. LANCET ONCOLOGY
- Prediction of Response in Melanoma Therapy by Systemic Inflammatory Response – One Size Fits Not All
- (2017) Georg Richtig et al. EBioMedicine
- Neutrophil to Lymphocyte Ratio is Associated With Outcome During Ipilimumab Treatment
- (2017) Michael R. Cassidy et al. EBioMedicine
- Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab
- (2016) P. F. Ferrucci et al. ANNALS OF ONCOLOGY
- Obesity accelerates T cell senescence in murine visceral adipose tissue
- (2016) Kohsuke Shirakawa et al. JOURNAL OF CLINICAL INVESTIGATION
- The Human Intestinal Microbiome in Health and Disease
- (2016) Susan V. Lynch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
- (2016) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overweight and obesity predict better overall survival rates in cancer patients with distant metastases
- (2016) Ngan Ming Tsang et al. Cancer Medicine
- Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patients
- (2015) P F Ferrucci et al. BRITISH JOURNAL OF CANCER
- Obesity and cancer immunotherapy toxicity
- (2015) Annie Mirsoian et al. Immunotherapy
- Could microbial therapy boost cancer immunotherapy?
- (2015) A. Snyder et al. SCIENCE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- American Society of Clinical Oncology Position Statement on Obesity and Cancer
- (2014) Jennifer A. Ligibel et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of obesity on the thickness of primary cutaneous melanoma
- (2014) F. Skowron et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
- (2014) Aurélien Trompette et al. NATURE MEDICINE
- Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival
- (2013) J. Delyon et al. ANNALS OF ONCOLOGY
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunological complications of obesity
- (2012) Thirumala-Devi Kanneganti et al. NATURE IMMUNOLOGY
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now